Researchers improve the genetic characterisation of the first experimental model of myelodysplastic syndromes June 13, 2025 Researchers improve the genetic characterisation of the first experimental model of myelodysplastic syndromes
New epigenetic targets identified for the potential treatment of multiple myeloma January 18, 2021 New epigenetic targets identified for the potential treatment of multiple myeloma
The INTERCEPT-MDS PhD fellowships to train Europe’s first experts in the emerging field of disease interception are open for applications. January 11, 2021 The INTERCEPT-MDS PhD fellowships to train Europe’s first experts in the emerging field of disease interception are open for applications.
Researchers from the Josep Carreras Institute received one of the five grants awarded worldwide by the Facebook founder’s Foundation to study COVID-19 December 31, 2020 Researchers from the Josep Carreras Institute received one of the five grants awarded worldwide by the Facebook founder’s Foundation to study COVID-19
Cancer cells resistant to treatment are already present before diagnosis of adult leukaemia December 16, 2020 Cancer cells resistant to treatment are already present before diagnosis of adult leukaemia
Discovered a new prognostic marker in a specific subtype of acute lymphoblastic leukemia (ALL) with adverse outcome in infants December 10, 2020 Discovered a new prognostic marker in a specific subtype of acute lymphoblastic leukemia (ALL) with adverse outcome in infants
Discovered the explanation of the patients with “lazarus-like” cancer November 30, 2020 Discovered the explanation of the patients with “lazarus-like” cancer
Seven investigators of the Josep Carreras Institute are recognized between the researchers with the most impact on world level November 26, 2020 Seven investigators of the Josep Carreras Institute are recognized between the researchers with the most impact on world level
Dr. Marcus Buschbeck leads the European Network INTERCEPT-MDS focusing on the shared training and research in Myeloid Diseases November 25, 2020 Dr. Marcus Buschbeck leads the European Network INTERCEPT-MDS focusing on the shared training and research in Myeloid Diseases
Manel Esteller is referred as Highly Cited Researcher According to 2020 Web of Science Group List November 18, 2020 Manel Esteller is referred as Highly Cited Researcher According to 2020 Web of Science Group List
New biomedical proteomics unit to boost personalised medicine, led by IRB Barcelona in collaboration with the Josep Carreras Leukaemia Research Institute November 17, 2020 New biomedical proteomics unit to boost personalised medicine, led by IRB Barcelona in collaboration with the Josep Carreras Leukaemia Research Institute
